Skip to content
Home
Site Map
Contact DCP
Search
Research Groups
Major Programs
Resources for Investigators
Publications
Prevention Clinical Trials
Screening and Early Detection Clinical Trials
Supportive and Palliative Care Clinical Trials
Clinical Trials Management
Preventing & Detecting Specific Cancers
Latest News
Meetings and Events
Scientific Scope
Research Groups and Offices
Research Networks
Staff Directory
Fellowships & Positions
Contact DCP
Latest News
Meetings and Events
Meetings and Events Archive
Molecular Targets for Dietary Prevention of Prostate Cancer
Agenda
June 16, 2000
8:30 - 8:45 am
Welcome
Carolyn K Clifford
8:45 - 8:50 am
Introduction to Workshop
Peter Greenwald
Studies of Diet and Prostate Cancer in Humans
Moderator: Carolyn K Clifford
8:50 - 9:10 am
Epidemiological Evidence for Diet and Prostate Cancer Relationship
Meir Stampfer
9:10 - 9:30 am
Ongoing Clinical Trials of Prostate Cancer
Howard Parnes
Experimental Evidence Supporting Specific Dietary Factors
Moderator: Young S Kim
9:30 - 9:55 am
Dietary Lipids
David Heber
9:55 - 10:20 am
Arachidonic Acid and Cell Proliferation
Charles E Myers
10:20 - 10:40 am
BREAK
10:40 - 11:05 am
Soy Products and Genistein
Stephen Barnes
11:05 - 11:30 am
Vitamin D
Robert H
Getzenberg
11:30 - 11:55 am
Molecular Markers for Prostate Cancer
Angelo M De Marzo
11:55 am - 12:20 pm
Transgenic Animal Models
Jeffrey E Green
12:20 - 1:20 pm
LUNCH
Panel Discussion and Recommendations for Future Directions
Moderator: John Milner
Panels:
Leland W Chung
Meir Stampfer
Stephen Barnes
Samson T Jacob
Robert H Getzenberg
Angelo M De Marzo
Barbara C Pence
David Heber
Jeffrey E Green
Harold Adelman
Charles E Myers
1:20 - 3:30 pm
Future Directions for Nutrition - Prostate Cancer Prevention Research
Which nutritional interventions appear to be most promising to decrease prostate cancer risk?
Which high risk groups should be targeted?
Which potential dietary and/or prostate specific molecular markers should be explored as intermediate end point measurements?
Which potential dietary and/or prostate specific molecular markers should be explored as intermediate end point measurements?
Which molecular targets and gene - nutrient interactions should be investigated?
Which of the prostate cancer animal models are most appropriate for nutrition-prostate cancer prevention research? What are the sources and the availability of these models?
What can the NCI do to enhance interdisciplinary collaborations?
3:30 pm
ADJOURNMENT
Back to top